Quantitative Biology > Quantitative Methods
[Submitted on 27 Oct 2022]
Title:Drug repositioning for Alzheimer's disease with transfer learning
View PDFAbstract:Deep Learning and DRUG-seq (Digital RNA with perturbation of genes) have attracted attention in drug discovery. However, the public DRUG-seq dataset is too small to be used for directly training a deep learning neural network from scratch. Inspired by the transfer learning technique, we pretrain a drug efficacy prediction neural network model with the Library of Integrated Network-based Cell-Signature (LINCS) L1000 data and then use human neural cell DRUG-seq data to fine-tune it. After training, the model is used for virtual screening to find potential drugs for Alzheimer's disease (AD) treatment. Finally, we find 27 potential drugs for AD treatment including Irsogladine (PDE4 inhibitor), Tasquinimod (HDAC4 selective inhibitor), Suprofen (dual COX-1/COX-2 inhibitor) et al.
References & Citations
Bibliographic and Citation Tools
Bibliographic Explorer (What is the Explorer?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)
Code, Data and Media Associated with this Article
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)
Demos
Recommenders and Search Tools
Influence Flower (What are Influence Flowers?)
Connected Papers (What is Connected Papers?)
CORE Recommender (What is CORE?)
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.